Literature DB >> 23797178

Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors.

Ikuyo Imayama1, Catherine M Alfano, Marian L Neuhouser, Stephanie M George, Ashley Wilder Smith, Richard N Baumgartner, Kathy B Baumgartner, Leslie Bernstein, Ching-Yun Wang, Catherine Duggan, Rachel Ballard-Barbash, Anne McTiernan.   

Abstract

Maintaining weight is important for better prognosis of breast cancer survivors. The associations between weight and cancer-related symptoms are not known. We examined associations among weight, weight change, inflammation, cancer-related symptoms, and health-related quality of life (HRQOL) in a cohort of stage 0-IIIA breast cancer survivors. Participants were recruited on average 6 months (2–12 months) after diagnosis. Height, weight, and C-reactive protein (CRP) were assessed at approximately 30 months post-diagnosis; cancer-related symptoms (chest wall and arm symptoms, vasomotor symptoms, urinary incontinence, vaginal symptoms, cognition/mood problems, sleep, sexual interest/function), and HRQOL (SF-36) were assessed at approximately 40 months post-diagnosis. Weight was measured at baseline in a subset. Data on 661 participants were evaluable for body mass index (BMI); 483 were evaluable for weight change. We assessed associations between BMI (<25.0, 25.0–29.9, ≥30.0 kg/m2), post-diagnosis weight change (lost ≥5 %, weight change <5 %, gained ≥5 %), and CRP (tertile) with cancer-related symptoms and HRQOL using analysis of covariance. Higher symptoms scores indicate more frequent or severe symptoms. Higher HRQOL scores indicate better HRQOL. Compared with those with BMI <25 kg/m2, women with BMI ≥30 kg/m2 had the following scores: increased for arm symptoms (+25.0 %), urinary incontinence (+40.0 %), tendency to nap (+18.9 %), and poorer physical functioning (−15.6 %, all p < 0.05). Obese women had lower scores in trouble falling asleep (−9.9 %; p < 0.05). Compared with weight change <5 %, participants with ≥5 % weight gain had lower scores in physical functioning (−7.2 %), role-physical (−15.5 %) and vitality (−11.2 %), and those with weight loss ≥5 % had lower chest wall (−33.0 %) and arm symptom scores (−35.5 %, all p < 0.05). Increasing CRP tertile was associated with worse scores for chest wall symptoms, urinary incontinence, physical functioning, role-physical, vitality and physical component summary scores (all P trend < 0.05). Future studies should examine whether interventions to maintain a healthy weight and reduce inflammation could alleviate cancer-related symptoms and improve HRQOL.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23797178      PMCID: PMC3772666          DOI: 10.1007/s10549-013-2594-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  69 in total

1.  The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

Authors:  R D Hays; J M Woolley
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations.

Authors:  C A Schag; R L Heinrich; R L Aadland; P A Ganz
Journal:  Health Psychol       Date:  1990       Impact factor: 4.267

3.  Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors.

Authors:  Bette J Caan; Jennifer A Emond; H Irene Su; Ruth E Patterson; Shirley W Flatt; Ellen B Gold; Vicky A Newman; Cheryl L Rock; Cynthia A Thomson; John P Pierce
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

4.  Body mass index and common mental disorders: exploring the shape of the association and its moderation by age, gender and education.

Authors:  R L McCrea; Y G Berger; M B King
Journal:  Int J Obes (Lond)       Date:  2011-03-22       Impact factor: 5.095

Review 5.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

6.  Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report.

Authors:  Kathleen Meeske; Ashley Wilder Smith; Catherine M Alfano; Bonnie A McGregor; Anne McTiernan; Kathy B Baumgartner; Kathleen E Malone; Bryce B Reeve; Rachel Ballard-Barbash; Leslie Bernstein
Journal:  Qual Life Res       Date:  2007-04-25       Impact factor: 4.147

Review 7.  Prognosis of the upper limb following surgery and radiation for breast cancer.

Authors:  Teresa S Lee; Sharon L Kilbreath; Kathryn M Refshauge; Robert D Herbert; Jane M Beith
Journal:  Breast Cancer Res Treat       Date:  2007-09-26       Impact factor: 4.872

Review 8.  Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.

Authors:  Electra D Paskett; Julie A Dean; Jill M Oliveri; J Phil Harrop
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

9.  Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.

Authors:  Brandon L Pierce; Marian L Neuhouser; Mark H Wener; Leslie Bernstein; Richard N Baumgartner; Rachel Ballard-Barbash; Frank D Gilliland; Kathy B Baumgartner; Bess Sorensen; Anne McTiernan; Cornelia M Ulrich
Journal:  Breast Cancer Res Treat       Date:  2008-04-10       Impact factor: 4.872

10.  Weight loss in mildly to moderately obese patients with obstructive sleep apnea.

Authors:  P L Smith; A R Gold; D A Meyers; E F Haponik; E R Bleecker
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

View more
  37 in total

1.  C-reactive protein as an available biomarker determining mental component of health-related quality of life among individuals with spinal cord injury.

Authors:  Hadis Sabour; Sahar Latifi; Zahra Soltani; Hania Shakeri; Abbas Norouzi Javidan; Seyed-Mohammad Ghodsi; Mohammad Reza Hadian; Seyed-Hassan Emami Razavi
Journal:  J Spinal Cord Med       Date:  2016-02-25       Impact factor: 1.985

2.  A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer.

Authors:  Mona Kamal; Xin Shelley Wang; Qiuling Shi; Tito Mendoza; Araceli Garcia-Gonzalez; Raza H Bokhari; Charles S Cleeland; David R Fogelman
Journal:  J Pain Symptom Manage       Date:  2020-01-24       Impact factor: 3.612

3.  Obesity, ethnicity, and quality of life among breast cancer survivors and women without breast cancer: the long-term quality of life follow-up study.

Authors:  Avonne E Connor; Richard N Baumgartner; Christina M Pinkston; Stephanie D Boone; Kathy B Baumgartner
Journal:  Cancer Causes Control       Date:  2015-10-30       Impact factor: 2.506

4.  Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors.

Authors:  Wendy Demark-Wahnefried; Graham A Colditz; Cheryl L Rock; Rebecca L Sedjo; Jingxia Liu; Kathleen Y Wolin; Helen Krontiras; Tim Byers; Bilgé Pakiz; Barbara A Parker; Michael Naughton; Anthony Elias; Patricia A Ganz
Journal:  Breast Cancer Res Treat       Date:  2015-10-31       Impact factor: 4.872

5.  Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.

Authors:  Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Wendy Demark-Wahnefried; Don Dizon; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Kristin Leonardi-Warren; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; Muhammad Raza; M Alma Rodriguez; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-10       Impact factor: 11.908

6.  Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial.

Authors:  Bilgé Pakiz; Patricia A Ganz; Rebecca L Sedjo; Shirley W Flatt; Wendy Demark-Wahnefried; Jingxia Liu; Kathleen Y Wolin; Cheryl L Rock
Journal:  Psychooncology       Date:  2015-04-29       Impact factor: 3.894

7.  Diet Quality, Inflammation, and Quality of Life in Breast Cancer Survivors: A Cross-Sectional Analysis of Pilot Study Data.

Authors:  Tonya S Orchard; Rebecca R Andridge; Lisa D Yee; Maryam B Lustberg
Journal:  J Acad Nutr Diet       Date:  2017-12-09       Impact factor: 4.910

8.  Resistance training reduces inflammation and fatigue and improves physical function in older breast cancer survivors.

Authors:  Monica C Serra; Alice S Ryan; Heidi K Ortmeyer; Odessa Addison; Andrew P Goldberg
Journal:  Menopause       Date:  2018-02       Impact factor: 2.953

9.  Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.

Authors:  Rebecca L Sedjo; Shirley W Flatt; Tim Byers; Graham A Colditz; Wendy Demark-Wahnefried; Patricia A Ganz; Kathleen Y Wolin; Anthony Elias; Helen Krontiras; Jingxia Liu; Michael Naughton; Bilgé Pakiz; Barbara A Parker; Holly Wyatt; Cheryl L Rock
Journal:  Support Care Cancer       Date:  2016-03-05       Impact factor: 3.603

10.  Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors.

Authors:  Rebecca L Sedjo; Tim Byers; Patricia A Ganz; Graham A Colditz; Wendy Demark-Wahnefried; Kathleen Y Wolin; Maria Azrad; Cheryl L Rock
Journal:  J Cancer Surviv       Date:  2014-03-06       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.